# Hyperthermia Enhanced Re-irradiation of Loco-regional Recurrent Tumors

Source: https://onco.cc/trials/nct04889742/  
OnCo record `nct04889742` (Trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

A phase 2 trial in colorectal cancer, run by Charite University, Berlin, Germany, not yet recruiting.

## Summary

Hyperthermia Enhanced Re-irradiation of Loco-regional Recurrent Tumors is a phase 2, interventional study registered as NCT04889742 by Charite University, Berlin, Germany, with a registry enrolment figure of 110 participants, started 2024-05-10 and due to reach its primary completion in 2026-01. Interventions recorded: loco-regional hyperthermia. Conditions listed: Recurrent Cancer; Prostate Cancer; Cervical Cancer; Anal Cancer; Sarcoma; Rectal Cancer; Neuroendocrine Tumors; Esophageal Cancer; Pancreas Cancer; Squamous Cell Carcinoma. Primary outcome: Local tumor recurrence. Sites: Germany. No results are recorded here; the registry entry is the source.

## Fields

- Kind: Trial
- Status: planned
- Last checked: 2026-09-24
- Also known as: HETERERO
- Tags: ctgov-ingest; colorectal-deep-dive
- Registry id: NCT04889742
- Phase: 2
- Setting: Hyperthermia Enhanced Re-irradiation of Loco-regional Recurrent Tumors
- Sponsor: Charite University, Berlin, Germany
- Enrolled: 110

## Sources

- ClinicalTrials.gov NCT04889742: https://clinicaltrials.gov/study/NCT04889742

## Connected records

- cancers: [Rectal cancer](https://onco.cc/cancers/rectal-cancer/)
- terms: [Colorectal cancer trials open today (registry snapshot)](https://onco.cc/terms/colorectal-trials-open-today/)

---
JSON: https://onco.cc/api/v1/entities/nct04889742.json